Roivant Sciences Ltd (NASDAQ: ROIV) is -6.93% lower on its value in year-to-date trading and has touched a low of $8.73 and a high of $13.06 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ROIV stock was last observed hovering at around $11.00 in the last trading session, with the day’s gains setting it 0.01%.
Currently trading at $11.01, the stock is 9.42% and 5.94% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 8.02 million and changing 0.09% at the moment leaves the stock -2.17% off its SMA200. ROIV registered 0.64% gain for a year compared to 6-month loss of -6.14%. The firm has a 50-day simple moving average (SMA 50) of $10.393 and a 200-day simple moving average (SMA200) of $11.25425.
The stock witnessed a 5.46% gain in the last 1 month and extending the period to 3 months gives it a -1.43%, and is 8.47% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.95% over the week and 4.27% over the month.
Roivant Sciences Ltd (ROIV) has around 908 employees, a market worth around $7.86B and $97.56M in sales. Profit margin for the company is -119.54%. Distance from 52-week low is 26.12% and -15.66% from its 52-week high. The company has generated returns on investments over the last 12 months (-2.21%).
with sales reaching $62.17M over the same period.The EPS is expected to shrink by -109.96% this year, but quarterly earnings will post 13.24% year-over-year. Quarterly sales are estimated to grow 114.89% in year-over-year returns.
Roivant Sciences Ltd (ROIV) Top Institutional Holders
399.0 institutions hold shares in Roivant Sciences Ltd (ROIV), with institutional investors hold 110.71% of the company’s shares. The shares outstanding are 719.63M, and float is at 438.55M with Short Float at 11.68%. Institutions hold 80.07% of the Float.
The top institutional shareholder in the company is SB INVESTMENT ADVISERS (UK) LTD with over 71.36 million shares valued at $754.29 million. The investor’s holdings represent 9.6983% of the ROIV Shares outstanding. As of 2024-06-30, the second largest holder is VIKING GLOBAL INVESTORS LP with 69.16 million shares valued at $730.98 million to account for 9.3985 of the shares outstanding. The other top investors are QVT FINANCIAL LP which holds 66.72 million shares representing 9.0674% and valued at over $705.23 million, while FMR LLC holds 6.3265 of the shares totaling 46.55 million with a market value of $492.05 million.
Roivant Sciences Ltd (ROIV) Insider Activity
The most recent transaction is an insider sale by Venker Eric, the company’s President & COO. SEC filings show that Venker Eric sold 100,000 shares of the company’s common stock on Apr 21 ’25 at a price of $10.22 per share for a total of $1.02 million. Following the sale, the insider now owns 1.12 million shares.
Still, SEC filings show that on Mar 24 ’25, Venker Eric (President & COO) disposed off 434,478 shares at an average price of $10.82 for $4.7 million. The insider now directly holds 1,127,290 shares of Roivant Sciences Ltd (ROIV).
